AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 14749690
Drug: Buprenorphine 8
RxNorm normalized name: buprenorphine 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine 8 mg daily
Trial: 11919661
Drug: Buprenorphine 16
RxNorm normalized name: buprenorphine 16 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine 16 mg daily
Trial: 2038044
Drug: Additional measures
RxNorm normalized name: MEASLES VIRUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Additional measures of diabetes-related health beliefs, diabetic daily hassles, perceived stress, diabetic adherence, and psychiatric symptoms
Trial: 1443440
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment for 6 weeks
Trial: 3134518
Drug: Long-term antihypertensive
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term antihypertensive treatment
Trial: 19716683
Drug: Atomoxetine (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine (up to 1.2 mg/kg/day)
Trial: 11405286
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg risedronate as a tablet
Trial: 11405286
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg risedronate as an aqueous solution
Trial: 11405286
Drug: 0.3 mg
RxNorm normalized name: biotin 0.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg risedronate as an intravenous infusion
Trial: 29133948
Drug: Anti-depressant medications
RxNorm normalized name: pramoxine hydrochloride Medicated Pad [Scalpicin Anti-Itch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-depressant medications (ADMs): escitalopram, sertraline, or venlafaxine-extended release for 8 weeks
Trial: 27863515
Drug: Enhanced treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enhanced treatment as usual (ETAU), n = 35
Trial: 16988115
Drug: PSY+PS cookie
RxNorm normalized name: PS
DrugBank: Phosphatidyl serine (DB00144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PSY+PS cookie (7.68 g/d PSY and 2.6 g/d PS)
Trial: 14574660
Drug: BUN >=
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BUN >= 15 mg/dL (sensitive cutpoint)
Trial: 14574660
Drug: BUN >=
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BUN >= 20 mg/dL (high-yield cutpoint)
Trial: 8957978
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of EEG, MLAEP, MAP and T measures
Trial: 1551309
Drug: Rice (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rice (50 g carbohydrate) eaten as part of a mixed meal (32 g protein, 20 g fat)
Trial: 1551309
Drug: Glucose (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose (50 g carbohydrate) eaten as part of a mixed meal (32 g protein, 20 g fat)
Trial: 1551309
Drug: Glucose (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose (50 g carbohydrate) eaten alone
Trial: 19963333
Drug: Alendronate 70
RxNorm normalized name: ALENDRONATE 70MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 70 mg once weekly for 8 weeks
Trial: 12145004
Drug: SE-enriched spread
RxNorm normalized name: Selenomethionine Se-75
DrugBank: Selenomethionine Se-75 (DB09400)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SE-enriched spread (18.2 +/- 1.5 g SE spread/d, corresponding to 1.60 +/- 0.13 g SEs)
Trial: 10456525
Drug: 0.2 mg/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg/kg/day subcutaneous recombinant human growth hormone (rhGH)
Trial: 526527
Drug: Different sets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Different sets of treatments
Trial: 30253697
Drug: Tribulus terrestris
RxNorm normalized name: TRIBULUS TERRESTRIS
DrugBank: Tribulus terrestris (DB14358)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tribulus terrestris (3 times daily for 3 months)
Trial: 17295580
Drug: Active medication
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active medication (Sertraline)
Trial: 15895833
Drug: Glutamate injections
RxNorm normalized name: glutamate
DrugBank: Leucovorin (DB00650)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Glutamate injections (1.0 mol/L)
Trial: 15895833
Drug: Isotonic saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic saline injections (0.165 mol/L)
Trial: 12795239
Drug: 0.15 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.15 mg/kg i.v. bolus
Trial: 12795239
Drug: 0.04 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.04 mg/kg i.m. injection
Trial: 12795239
Drug: 0.04 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.04 mg/kg i.v. infusion
Trial: 385100
Drug: Cimetidine, 1.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine, 1.6 g daily for six months
Trial: 29697291
Drug: Vildagliptin (vild)
RxNorm normalized name: vildagliptin
DrugBank: Vildagliptin (DB04876)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Vildagliptin (vild) plus standard medical treatment
Trial: 27733159
Drug: No statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No statin therapy
Trial: 15383370
Drug: rhIL-6 infusion
RxNorm normalized name: rhIL-15
DrugBank: Interleukin-15, human recombinant (DB17467)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhIL-6 infusion for 3 hours
Trial: 6624851
Drug: Oral habilitation
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein, A, recombinant, stabilized / respiratory syncytial virus pre-fusion F protein, B, recombinant, stabilized Injection [Abrysvo]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral habilitation program (sensorimotor facilitation procedures)
Trial: 23116500
Drug: Orthodontic miniscrew
RxNorm normalized name: monofluorophosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orthodontic miniscrew implants
Trial: 11815967
Drug: High-dose-rate (HDR)
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose-rate (HDR) intracavitary radiation therapy
Trial: 11815967
Drug: Low-dose-rate (LDR)
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose-rate (LDR) intracavitary radiation therapy
Trial: 10431991
Drug: Oral anticoagulant
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anticoagulant (OC) treatment
Trial: 2098372
Drug: Low-dose subcutaneous
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose subcutaneous heparin (LDSH)
Trial: 31102063
Drug: CBT +
RxNorm normalized name: Cannabidiol
DrugBank: Cannabidiol (DB09061)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: CBT + Fluoxetine (COMB)
Trial: 26184461
Drug: risperidone long
RxNorm normalized name: Risperidone
DrugBank: Risperidone (DB00734)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: risperidone long acting injection
Trial: 24819857
Drug: Topical timolol‐dorzolamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical timolol‐dorzolamide fixed‐combination drops twice daily when IOP exceeded 10 mmHg
Trial: 24819857
Drug: Conventional stepwise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional stepwise treatment when IOP exceeded target pressure
Trial: 17442687
Drug: Etoricoxib (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etoricoxib (120 mg)
Trial: 12162474
Drug: Celecoxib (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib (200 mg)
Trial: 12271371
Drug: Topical anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical anesthesia (oxybutynin 0.4% eye drops and cocaine hydrochloride 10% eye drops)
Trial: 12271371
Drug: Retrobulbar anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Retrobulbar anesthesia (5 ml mepivacaine 2% injected into the retrobulbar space)
Trial: 10397541
Drug: Individualized, unrestricted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individualized, unrestricted antiretroviral therapy
Trial: 8642546
Drug: Inositol 6
RxNorm normalized name: inositol 650 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inositol 6 g daily for 5 days before the 5th or 6th ECT
Trial: 11691515
Drug: Quinapril 40
RxNorm normalized name: quinapril 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinapril 40 mg
Trial: 22607887
Drug: Early invasive
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early invasive therapy
Trial: 16490806
Drug: Dapoxetine 30
RxNorm normalized name: duloxetine 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapoxetine 30 mg
Trial: 1723550
Drug: KRN 8601
RxNorm normalized name: KRN-5500
DrugBank: KRN-5500 (DB15215)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KRN 8601 (75 micrograms/body, subcutaneous administration)
Trial: 1723550
Drug: KRN 8601
RxNorm normalized name: KRN-5500
DrugBank: KRN-5500 (DB15215)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KRN 8601 (100-200 micrograms/m2, intravenous drip infusion)
Trial: 7195890
Drug: Surgical-medical treatment
RxNorm normalized name: zinc pyrithione Medicated Shampoo [Head & Shoulders Damage Treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical-medical treatment (internal urethrotomy with antimicrobial agents)
Trial: 20051377
Drug: Sulindac 150
RxNorm normalized name: sulindac 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulindac 150 mg daily for 6 weeks
Trial: 9656160
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of coumarin
Trial: 8122728
Drug: Weekly donation
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly donation intervals
Trial: 2548815
Drug: Nedocromil sodium
RxNorm normalized name: Nedocromil Sodium
DrugBank: Nedocromil (DB00716)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nedocromil sodium (4 mg twice daily by inhalation)
Trial: 15001966
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg rifampin for 6 days
Trial: 9807607
Drug: Mivacurium 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mivacurium 0.15 mg/kg
Trial: 2465710
Drug: Mivacurium 0.20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mivacurium 0.20 mg/kg
Trial: 12975739
Drug: Mivacurium 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mivacurium 0.25 mg/kg
Trial: 31565753
Drug: Glutamine (0.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glutamine (0.9 g kg‐1 fat‐free mass)
Trial: 28487249
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of rightward prismatic adaptation (PA) and anodal transcranial direct current stimulation (tDCS) of the right motor cortex
Trial: 25205323
Drug: Ferritin concentration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ferritin concentration (0.29 per log‐mg/dl)
Trial: 25205323
Drug: RBP (0.27
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RBP (0.27 per mg/dl)
Trial: 21474643
Drug: Nebulized ceftazidime
RxNorm normalized name: Ceftazidime
DrugBank: Ceftazidime (DB00438)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nebulized ceftazidime (15 mg·kg(‐1)·3 h(‐1)) and amikacin (25 mg·kg(‐1)·d(‐1))
Trial: 21474643
Drug: Intravenous ceftazidime
RxNorm normalized name: Ceftazidime
DrugBank: Ceftazidime (DB00438)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ceftazidime (90 mg·kg(‐1)·d(‐1), continuous administration) and amikacin (15 mg·kg(‐1)·d(‐1))
Trial: 18708923
Drug: Cefuroxime (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefuroxime (1.5 g preoperative dose)
Trial: 16857835
Drug: Lactulose (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactulose (25 g/d)
Trial: 11827905
Drug: Amoxicillin (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin (25 mg/kg, twice daily for 5 days)
Trial: 11827905
Drug: Co-trimoxazole (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-trimoxazole (4 mg/kg trimethoprim plus 20 mg/kg sulphamethoxazole, twice daily for 5 days)
Trial: 10419992
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg vitamin A
Trial: 10419992
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg vitamin A (among malnourished infants)
Trial: 10419992
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg vitamin A (among well-nourished children)
Trial: 8693619
Drug: Salmeterol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol (50 micrograms twice daily)
Trial: 7966789
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no adjuvant treatment)
Trial: 31335248
Drug: Visits involving
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Visits involving discussion of chemotherapy
Trial: 7752174
Drug: celiprolol 200
RxNorm normalized name: celiprolol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: celiprolol 200 mg or 400 mg once daily
Trial: 7752174
Drug: metoprolol 100
RxNorm normalized name: metoprolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metoprolol 100 mg or 200 mg once daily
Trial: 25148789
Drug: Intravitreal ranibizumab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal ranibizumab 0.3 mg
Trial: 25148789
Drug: Intravitreal ranibizumab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal ranibizumab 0.5 mg
Trial: 18772894
Drug: CLA (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CLA (3 g daily) plus n-3 LC-PUFA (3 g daily)
Trial: 18772894
Drug: Control oil
RxNorm normalized name: SALICYLIC ACID 29.2 mg TOPICAL LIQUID [Acne Control oil-free Cleansing]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control oil (6 g daily)
Trial: 10202315
Drug: Theolong 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theolong 400 mg/day
Trial: 7771486
Drug: High blood
RxNorm normalized name: Cough & Cold High Blood Pressure Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High blood flow (400 mL/min) for 2 hours with cuprophan membrane
Trial: 7771486
Drug: High blood
RxNorm normalized name: Cough & Cold High Blood Pressure Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High blood flow (400 mL/min) for 2 hours
Trial: 6116855
Drug: PRP +
RxNorm normalized name: Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRP + P vaccine (with pertussis adjuvant)
Trial: 6116855
Drug: PRP vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRP vaccine alone
Trial: 29226471
Drug: Cenderitide (4-hour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cenderitide (4-hour infusion)
Trial: 2437837
Drug: Methylprednisolone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (1 mg/kg)
Trial: 28077104
Drug: Flutter® therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutter® therapy
Trial: 29605819
Drug: APIC intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: APIC intervention (weekly 3-hour personalised stimulation sessions for 12 months)
Trial: 22264202
Drug: NeuroFlo catheter
RxNorm normalized name: CATHETER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NeuroFlo catheter treatment
Trial: 19231633
Drug: A-002 (1-H-indole-3-glyoxamide)
RxNorm normalized name: heparinoids 0.002 MG/MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A-002 (1-H-indole-3-glyoxamide) 50 mg twice daily
Trial: 19231633
Drug: A-002 (1-H-indole-3-glyoxamide)
RxNorm normalized name: heparinoids 0.002 MG/MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A-002 (1-H-indole-3-glyoxamide) 100 mg twice daily
Trial: 19231633
Drug: A-002 (1-H-indole-3-glyoxamide)
RxNorm normalized name: heparinoids 0.002 MG/MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A-002 (1-H-indole-3-glyoxamide) 250 mg twice daily
Trial: 10742877
Drug: Family therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Family therapy and Family group psychoeducation
Trial: 8458314
Drug: Metronidazole +
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metronidazole + High energy supplement (3.31 MJ daily for 3 months)
Trial: 29956526
Drug: Pharmaceutical care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmaceutical care provided by community pharmacists in collaboration with diabetologists and diabetes advisors
Trial: 23809512
Drug: L-NMMA (nonselective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-NMMA (nonselective NO-inhibitor)
Trial: 12051214
Drug: Hypothetical pain
RxNorm normalized name: Dermoplast Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypothetical pain medication information leaflet
Trial: 12680738
Drug: Temazepam (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temazepam (20 mg)
Trial: 10941
Drug: Nitrazepam (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrazepam (10 mg)
Trial: 27037462
Drug: Long-interval misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-interval misoprostol (2 tablets of 400 μg at 12 hours and 2 placebo tablets at 3 hours before procedure)
Trial: 20678673
Drug: Donepezil 23
RxNorm normalized name: donepezil 23 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil 23 mg/d
Trial: 11810088
Drug: Sublingual misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual misoprostol (50 microg, repeated every 4 hours to a maximum of 5 doses)
Trial: 11810088
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol (50 microg, repeated every 4 hours to a maximum of 5 doses)
Trial: 10513854
Drug: Paroxetine (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (mean dose = 24.5 mg/day)
Trial: 10513854
Drug: Nortriptyline (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nortriptyline (mean dose = 51.3 mg/day; mean blood level = 85.5 ng/mL)
Trial: 7491235
Drug: RRV-S1 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RRV-S1 vaccine (4 x 10(4) plaque-forming units)
Trial: 7491235
Drug: RRV-TV vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RRV-TV vaccine (4 x 10(4) plaque-forming units)
Trial: 7491235
Drug: RRV-S1 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RRV-S1 vaccine
Trial: 1834395
Drug: Immediate-release disopyramide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release disopyramide (400 mg/day)
Trial: 1834395
Drug: Slow-release disopyramide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow-release disopyramide (500 mg/day)
Trial: 23236367
Drug: Single-dose albendazole
RxNorm normalized name: Albendazole
DrugBank: Albendazole (DB00518)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-dose albendazole during pregnancy
Trial: 23236367
Drug: Quarterly single-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quarterly single-dose albendazole during childhood
Trial: 20411695
Drug: Sleep restriction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sleep restriction therapy plus hypnotic withdrawal (SR+HW)
Trial: 15725695
Drug: Fluvastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin (20 mg/d) after crossover to Pravastatin
Trial: 15725695
Drug: Pravastatin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin (10 mg/d) after crossover to Fluvastatin
Trial: 15725695
Drug: Fluvastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin (20 mg/d) and Pravastatin (10 mg/d)
Trial: 8595682
Drug: Intramuscular meperidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular meperidine (50 mg) in the deltoid
Trial: 2653846
Drug: Radiotherapy +
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Radiotherapy + endocrine therapy
Trial: 2653846
Drug: Radiotherapy +
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Radiotherapy + chemotherapy
Trial: 2653846
Drug: Radiotherapy +
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Radiotherapy + endocrine therapy + chemotherapy
Trial: 2653846
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of hormone treatment and chemotherapy
Trial: 15047035
Drug: Propranolol (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (60 mg)
Trial: 21934690
Drug: Weekly docetaxel/gemcitabine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly docetaxel/gemcitabine followed by erlotinib (arm A)
Trial: 21934690
Drug: Erlotinib followed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erlotinib followed by weekly docetaxel/gemcitabine (arm B)
Trial: 8922653
Drug: Ibandronate 2.5
RxNorm normalized name: ibandronate 2.5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibandronate 2.5 mg